The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer-Reference-Cited by-同舟云学术

The Emerging Therapeutic Potential of Nitro Fatty Acids and Other Michael Acceptor-Containing Drugs for the Treatment of Inflammation and Cancer

Published:2020-09-03 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Piesche Matthias,Roos Jessica,Kühn Benjamin,Fettel Jasmin,Hellmuth Nadine,Brat Camilla,Maucher Isabelle V.,Awad Omar,Matrone Carmela,Comerma Steffensen Simon Gabriel,Manolikakes Georg,Heinicke Ulrike,Zacharowski Kai D.,Steinhilber Dieter,Maier Thorsten J.

Funder

Deutsche Forschungsgemeinschaft

Aarhus Universitets Forskningsfond

Else Kröner-Fresenius-Stiftung

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference166 articles.

1. : Ibrutinib and novel BTK inhibitors in clinical development;Akinleye;J. Hematol. Oncol.,2013

2. Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells;Asan;J. Biol. Chem.,2019

3. Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation;Awwad;Antioxidants Redox Signaling,2014